Access the full text.
Sign up today, get DeepDyve free for 14 days.
MFW Festing (1995)
Use of a multi-strain assay could improve the NTP carcinogenesis bioassay programEnviron Health Perspect, 103
J. Sontag, N. Page (1976)
Guidelines for carcinogen bioassay in small rodents.National Cancer Institute carcinogenesis technical report series, 1
R. Kempson, R. Mead (1989)
The Design of Experiments.The Statistician, 39
M. Festing (1995)
Use of a multistrain assay could improve the NTP carcinogenesis bioassay.Environmental Health Perspectives, 103
D. Altman (1982)
Statistics in medical journals.Statistics in medicine, 1 1
M. Balls, Alan Goldberg, J. Fentem, C. Broadhead, Rex Burch, Michael Festing, John Frazier, C. Hendriksen, M. Jennings, argot Kamp, David Morton, Andrew Rowan, Claire Russell, William Russell, Horst Spielmann, Martin Stephens, William Stokes, Donald Straughan, James Yager, J. Zurlo, Bert Zutphen (1995)
The Three Rs: The Way ForwardAlternatives to Laboratory Animals, 23
Michael Festing (1992)
The scope for improving the design of laboratory animal experimentsLaboratory Animals, 26
Virginia Papaioannou, Michael Festing (1980)
Genetic drift in a stock of laboratory miceLaboratory Animals, 14
M. Festing, D. Lovell (1995)
The need for statistical analysis of rodent micronucleus test data. Comment on the paper by Ashby and Tinwell.Mutation research, 329 2
MFW Festing, BJT Morgan (1996)
Are animal experiments in toxicological research the ‘right’ size?Statistics in toxicology
G. Nohynek, L. Longeart, B. Geffray, J. Provost, A. Lodola (1993)
Fat, Frail and Dying Young: Survival, Body Weight and Pathology of the Charles River Sprague-Dawley-Derived Rat Prior to and Since the Introduction of the VAFR Variant in 1988Human & Experimental Toxicology, 12
R. Fisher (1936)
Design of ExperimentsBritish Medical Journal, 1
(1982)
Genetic contamination of laboratory animal colonies : an increasingly serious problem
Michael Festing (1994)
Reduction of animal use: experimental design and quality of experimentsLaboratory Animals, 28
K. Gärtner (1990)
A third component causing random variability beside environment and genotype. A reason for the limited success of a 30 year long effort to standardize laboratory animals?Laboratory Animals, 24
R. Felton, D. Gaylor (1989)
Multistrain experiments for screening toxic substances.Journal of toxicology and environmental health, 26 4
S. Gore, I. Jones, E. Rytter (1977)
Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976.British Medical Journal, 1
(1968)
Genetic aspects of experimental animals in cancer research . Jpn Cancer Assoc
(1982)
Misuse of statistics is unethical
(1953)
BEDSIDE DIAGNOSISThe Ulster Medical Journal, 22
Elizabeth Russell, M. Festing (1981)
Inbred Strains in Biomedical ResearchBioScience
M. Festing (1993)
Genetic variation in outbred rats and mice and its implications for toxicological screening.Journal of experimental animal science, 35 5-6
J. I (1936)
The Design of ExperimentsNature, 137
(1968)
Genetic aspects of experimental animals in cancer research
M. Festing (1987)
Genetic factors in toxicology: implications for toxicological screening.Critical reviews in toxicology, 18 1
The controlled experiment is one of the most powerful tools available in biomedical research, and thousands of such experiments are conducted annually. However, the basic principles of designing such experiments do not seem to be widely understood. If the experimental material is heterogeneous, then the treated and control groups may not be identical at the start of the experiment, even if large sample sizes are used. Yet genetically heterogeneous ‘outbred’ stocks of laboratory mice and rats are widely used in the pharmaceutical industry in spite of the availability of more homogeneous inbred strains. The use of such stocks is justified on two grounds: that humans are also heterogeneous, and that such stocks offer a wide range of phenotypes for toxicological screening. Both arguments are spurious. It is not necessary for atoxicological model of humans to be a goodgenetic model. Models do not have to resemble their target in every respect. Were they to do so they would no longer be models. The genetic heterogeneity within an outbred stock simply creates ‘noise’ when comparing treated and control groups, and prevents more exact matching of groups before the experiment starts. Phenotypic heterogeneity can be achieved without this disadvantage using a factorial experimental design involving more than one strain, with groups exactly matched genetically, but without increasing total numbers.The lack of understanding of good experimental design seems to extend to other areas, with few research workers using techniques such as blocking and factorial experimental designs which have been known for over 60 years, and which are widely used in other disciplines. Experiments are often unnecessarily large and surveys suggest that more than half have obvious statistical errors. Better training in experimental design would be cost effective in making better use of scarce resources, and would help to reduce the use of laboratory animals, which is an ethically desirable goal.
Comparative Clinical Pathology – Springer Journals
Published: Dec 1, 1997
Keywords: Experimental design; Inbred strains; Outbred stocks; Statistics
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.